Hepatocellular Carcinoma Recurrence and Anesthesia

Seoul National University Bundang Hospital259 enrolled

Overview

The investigators will verify the prognosis of hepatocellular carcinoma (HCC) according to the main anesthetic agents used for the general anesthesia.

Study Type

OBSERVATIONAL

Enrollment

259

Conditions

Hepatocellular Carcinoma

Interventions

Volatile anestheticsOTHER

Intravenous anestheticsOTHER

Eligibility

Sex: ALLMin age: 20 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients undergoing surgery due to the HCC. Exclusion Criteria: * Patients undergoing re-operation due to the HCC. * Patients presenting distant metastasis. * Patients undergoing liver transplantation surgery.

Locations (1)

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea

Outcomes

Primary Outcomes

Recurrence of HCC

Time frame: Postoperative 2 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.